Regenxbio (RGNX) FCF Margin (2014 - 2025)
Regenxbio (RGNX) recorded quarterly FCF Margin of 169.01% in Q4 2025, up 10.98% quarter-over-quarter from 189.86% in Q3 2025, and down 1485.0% on a YoY basis from 12.2% in Q4 2024.
Regenxbio (RGNX) FCF Margin (2014 - 2025) Analysis & Trends
Regenxbio's FCF Margin history runs 12 years deep, the most recent figure standing at 169.01% for Q4 2025.
- In Q4 2025, FCF Margin fell 1485.0% year-over-year to 169.01%; the TTM figure through Dec 2025 stood at 73.25% (up 13743.0% YoY), while the FY2025 annual figure was 73.25%, up 13743.0% from the prior year.
- FCF Margin was 169.01% for Q4 2025 at Regenxbio, up from 189.86% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 82.0% in Q4 2021 to a low of 447.99% in Q1 2023.
- Historically, FCF Margin has averaged 207.21% across 5 years, with a median of 202.54% in 2021.
- The sharpest annual moves came in 2022 and 2025: FCF Margin tumbled 22506 bps in 2022, then jumped 39518 bps in 2025.
- A 5-year view of FCF Margin shows it stood at 82.0% in 2021, then plunged by 274 bps to 143.06% in 2022, then slumped by 32 bps to 188.57% in 2023, then gained by 18 bps to 154.16% in 2024, then declined by 10 bps to 169.01% in 2025.
- The last three FCF Margin figures came in at 169.01% (Q4 2025), 189.86% (Q3 2025), and 232.84% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -3.98% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Regenxbio | 315.11 Mn | 85.04 Mn | - | -169.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -169.01% |
| Sep 30, 2025 | -189.86% |
| Jun 30, 2025 | -232.84% |
| Mar 31, 2025 | 36.63% |
| Dec 31, 2024 | -154.16% |
| Sep 30, 2024 | -168.93% |
| Jun 30, 2024 | -206.19% |
| Mar 31, 2024 | -358.55% |
| Dec 31, 2023 | -188.57% |
| Sep 30, 2023 | -175.85% |
| Jun 30, 2023 | -249.78% |
| Mar 31, 2023 | -447.99% |
| Dec 31, 2022 | -143.06% |
| Sep 30, 2022 | -209.36% |
| Jun 30, 2022 | -217.42% |
| Mar 31, 2022 | -301.01% |
| Dec 31, 2021 | 82.00% |
| Sep 30, 2021 | -198.88% |
| Jun 30, 2021 | -253.75% |
| Mar 31, 2021 | -397.52% |